Northwestern Mutual Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.34K Sell
2,392
-500
-17% -$2.17K ﹤0.01% 3178
2025
Q4
$10.3K Sell
2,892
-1,239
-30% -$7.59K ﹤0.01% 2977
2025
Q3
$36.8K Sell
4,131
-8,916
-68% -$90.4K ﹤0.01% 2454
2025
Q2
$120K Sell
13,047
-1,824
-12% -$15.6K ﹤0.01% 1938
2025
Q1
$128K Sell
14,871
-12,698
-46% -$120K ﹤0.01% 1840
2024
Q4
$296K Buy
+27,569
New +$212K ﹤0.01% 1501
2023
Q4
Sell
-1,335
Closed -$8.74K 3479
2023
Q3
$8.74K Buy
+1,335
New +$10.6K ﹤0.01% 2584

Other funds holding AVXL

Northwestern Mutual Wealth Management's AVXL Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Anavex Life Sciences (AVXL) stake by 17% in Q1 2026, selling an estimated $2.17K and leaving 2,392 shares worth $7.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3178.

Northwestern Mutual Wealth Management first reported a position in AVXL in Q3 2023 and has held it in 7 quarters since. The position peaked at $296K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2,392 shares of Anavex Life Sciences worth $7.34K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 500 Anavex Life Sciences shares in Q1 2026, an estimated $2.17K.
  • Anavex Life Sciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3178 holding.
  • Northwestern Mutual Wealth Management first reported a position in Anavex Life Sciences in Q3 2023 and has held it in 7 quarters since.
  • Northwestern Mutual Wealth Management's Anavex Life Sciences position peaked at $296K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.